Furthermore, oncogenic and immune checkpoint proteins, such as EGFR, ALK, KRAS G12C, and PD-L1, which are well-established in lung cancer, could be monitored in fibrotic patients to detect early malignancy or to guide preventive therapies [124]. The gene discussed is EGFR; the disease is lung cancer.